RT Journal Article
SR Electronic
T1 Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 145
DO 10.1186/s40425-019-0623-z
VO 7
IS 1
A1 Andtbacka, Robert H. I.
A1 Collichio, Frances
A1 Harrington, Kevin J.
A1 Middleton, Mark R.
A1 Downey, Gerald
A1 Ӧhrling, Katarina
A1 Kaufman, Howard L.
YR 2019
UL http://jitc.bmj.com/content/7/1/145.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.